ARISTO — Aristo Bio-Tech and Lifescience Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Aristo Bio-Tech and Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1.12	4.16	18.5	6.37	11.2
Net Total Accounts Receivable
Net Total Receivables	370	378	498	638	667
Total Inventory
Total Other Current Assets
Total Current Assets	691	625	831	1,050	1,158
Net Property, Plant And Equipment	123	145	167	217	240
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	814	770	998	1,273	1,406
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	560	510	595	836	956
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	680	622	697	937	1,033
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	134	148	302	336	373
Total Liabilities & Shareholders' Equity	814	770	998	1,273	1,406
Total Common Shares Outstanding